Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in a wide variety of diseases, from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, immunodeficiencies) to those in which altered immunity and inflammation define the pathological outcomes (chronic infections, tumors, chronic inflammatory and degenerative diseases, metabolic disorders, etc.). This brief review will summarize some of the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression, by considering the following aspects: - molecular pathways: investigating the fine mechanisms of immune modulation, to define novel targets and new clinical applications, with particular emphasis to approaches for re-education of anomalous immunity, including induction of tolerance. - personalized medicine: how pharmacogenomics can help in selecting the optimal treatment for each patient, focusing on human immunology for obtaining relevant information that animal models cannot provide. - microbiome: considering immune responses as the result of the interaction between human cells and commensal bacteria, for a new perspective in the use of immunosuppressive treatments. - natural products: providing a scientific basis to the huge body of pharmacological knowledge and products of traditional medicine for identifying new active molecules and new treatment concepts. - nanomedicine: exploiting the intelligent design of engineered nanoparticles offered by nanotechnologies in tailoring shape-, size-, surface-controlled carriers for targeted delivery of drugs. © 2013 Elsevier B.V. All rights reserved.
Perspectives in immunopharmacology: The future of immunosuppression
Boraschi D;
2014
Abstract
Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in a wide variety of diseases, from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, immunodeficiencies) to those in which altered immunity and inflammation define the pathological outcomes (chronic infections, tumors, chronic inflammatory and degenerative diseases, metabolic disorders, etc.). This brief review will summarize some of the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression, by considering the following aspects: - molecular pathways: investigating the fine mechanisms of immune modulation, to define novel targets and new clinical applications, with particular emphasis to approaches for re-education of anomalous immunity, including induction of tolerance. - personalized medicine: how pharmacogenomics can help in selecting the optimal treatment for each patient, focusing on human immunology for obtaining relevant information that animal models cannot provide. - microbiome: considering immune responses as the result of the interaction between human cells and commensal bacteria, for a new perspective in the use of immunosuppressive treatments. - natural products: providing a scientific basis to the huge body of pharmacological knowledge and products of traditional medicine for identifying new active molecules and new treatment concepts. - nanomedicine: exploiting the intelligent design of engineered nanoparticles offered by nanotechnologies in tailoring shape-, size-, surface-controlled carriers for targeted delivery of drugs. © 2013 Elsevier B.V. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
